With Reagent Red Cells, Quality Matters more than Quantity:
A robust reaction is great. The ability to get to an answer with the first identification panel is even better! Homozygous antigen expression allows you to tease apart multiple specificities without running additional selected cells. Contact your Quotient Account Executive to compare our antigen profiles (and our prices) to your current supplier.
Science & Health
T-cell therapy performs well against leukemia in new study Nineteen patients with relapsing or unresponsive acute lymphoblastic leukemia remained in remission six months after being treated with genetically engineered autologous T-cells, researchers at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania report in The New England Journal of Medicine. The therapy used T-cells reprogrammed to find and destroy B-cells that have the surface protein CD19. Researchers at the National Cancer Institute and Memorial Sloan Kettering Cancer Center have reported similar results with the therapy.The New York Times (tiered subscription model)
Track Hemoglobin Changes in Real Time
- Noninvasive and continuous hemoglobin (SpHb®) monitoring
- Enhance patient care with real-time visibility to whether hemoglobin is stable, dropping, or rising
Agena Bioscience Workshop on Blood Group Genotyping
Hear immunohematologists from four renowned institutions share their experiences with the new Hemo ID Blood Group Genotyping Panel and the MassARRAY System. The discussion will include validation vs. serotyping, high throughput donor screening, and resolution of complex RH genotypes. RSVP HERE for the breakfast workshop on October 27 at 7:00 AM.
Canada funds 12 translational genomics projects The Canadian government will invest more than $13 million and partners in Genome Canada's Genomic Applications Partnership Program will invest another $36 million to fund 12 genomics research projects. Projects include developing an inexpensive diagnostic platform for infectious disease testing, creating a treatment for vascular inflammation and destabilization, finding more effective ways to match drug therapies to mental health patients, and creating a cardiovascular biomarker translation program to combat heart failure.GenomeWeb Daily News (free registration)
AABB Annual Meeting Industry Workshop
Don't miss the Industry Workshop sponsored by Immucor at the AABB Annual Meeting on Sunday, October 26 at 7am in the Convention Center Room 107A/B. Please join us to learn about "Evolution Practices: IVD Molecular Immunohematology & Platelet Refractory Investigations". Click here for a complete list of educational opportunities sponsored by Immucor.
FDA approves Chimerix's trials of experimental Ebola drug The FDA has permitted Chimerix to conduct clinical trials to test brincidofovir, its experimental broad-spectrum antiviral drug, against Ebola. The emergency investigational new drug application submitted by the company was supported by data from in vitro assessments and ongoing animal testing.FDAnews
FedEx & UPS Refunds Now Available!
AABB members are eligible for refunds from both carriers. Up to 6% of shipping budgets are eligible for refunds. Overnight shippers have a higher rate of eligible refunds. 71lbs now serving the needs of AABB members. Watch this 90 second video to learn more now!